- Trials with a EudraCT protocol (27)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (18)
27 result(s) found for: Abdominal aortic aneurysm repair.
Displaying page 1 of 2.
EudraCT Number: 2009-013441-28 | Sponsor Protocol Number: prot.8.6.2009 | Start Date*: 2009-09-30 | ||||||||||||||||||||||||||||||||||||||||||||||
Sponsor Name:Copenhagen University Hospital, Rigshospitalet | ||||||||||||||||||||||||||||||||||||||||||||||||
Full Title: POMEVAR : PreOperative Methylprednisolone in EndoVascular Aortic Repair - a randomized, double-blind, placebocontrolled trial. | ||||||||||||||||||||||||||||||||||||||||||||||||
Medical condition: Asymptomatic abdominal aortic aneurysms | ||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||||||||||||||||||||||
Trial protocol: DK (Completed) | ||||||||||||||||||||||||||||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2006-006105-86 | Sponsor Protocol Number: 2006AAARamipril | Start Date*: 2007-05-11 | |||||||||||
Sponsor Name:LUMC | |||||||||||||
Full Title: The effect of pre-operative Ramipril treatment on vascular inflammation in the abdominal aneurysm | |||||||||||||
Medical condition: An aneurysm of the abdominal aorta | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-004124-20 | Sponsor Protocol Number: 200701234 | Start Date*: 2007-10-10 | |||||||||||
Sponsor Name:LUMC | |||||||||||||
Full Title: Doxycycline for Stabilization of Abdominal Aortic Aneurysms | |||||||||||||
Medical condition: Abdominal aortic aneurysm | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-007468-41 | Sponsor Protocol Number: 7563 | Start Date*: 2009-05-11 | |||||||||||
Sponsor Name:LUMC | |||||||||||||
Full Title: STUDY ON PLEIOTROPE EFFECTS OF HIGH DOSE STATIN IN THE COMMENCEMENT OF INFLAMMATORY PROCESSES IN THE ABDOMINAL AORTIC ANEURYSM WALL. | |||||||||||||
Medical condition: Abdomina; aortic aneurysm | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-000214-37 | Sponsor Protocol Number: Wallstrength_01 | Start Date*: 2007-08-07 | |||||||||||
Sponsor Name:UMC St Radboud | |||||||||||||
Full Title: Biological and biochemical markers of aneurysm wall degradation; towards non-invasive wall strength analysis. | |||||||||||||
Medical condition: Abdominal aortic aneurysms. Biomarkers related to diminished aneurysm wall strength. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-004289-33 | Sponsor Protocol Number: MAAAGI | Start Date*: 2019-12-12 |
Sponsor Name:Department of Surgical, Sciences Uppsala University | ||
Full Title: Metformin for Abdominal Aortic Aneurysm Inhibition A randomized controlled trial MAAAGI trial | ||
Medical condition: Small abdominal aortic aneurysm (AAA) under active surveillance; 30-49 mm in diameter for men and 30-44 mm in diameter for women | ||
Disease: | ||
Population Age: Elderly | Gender: Male, Female | |
Trial protocol: SE (Trial now transitioned) DK (Trial now transitioned) | ||
Trial results: (No results available) |
EudraCT Number: 2016-000692-24 | Sponsor Protocol Number: EVARBD | Start Date*: 2017-04-05 | |||||||||||
Sponsor Name:AZIENDA USL TOSCANA SUD EST Sezione di Arezzo | |||||||||||||
Full Title: "Evaluation of efficacy and accuracy of a CTA low dose protocol for Pazients with EVAR" | |||||||||||||
Medical condition: Patients with aortic aneurism who underwent to endovascular repair of aortic aneurism. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-000285-35 | Sponsor Protocol Number: Cardoz-003 | Start Date*: 2011-05-09 | |||||||||||
Sponsor Name:Cardoz AB | |||||||||||||
Full Title: An international, multi-centre, randomised, stratified, double-blinded, placebo-controlled, 4-parallel group trial investigating the efficacy and safety of three different dose levels of CRD007 a... | |||||||||||||
Medical condition: Abdominal aortic aneurysm (AAA) is a dilatation of the aorta as it passes through the abdomen, defined as a dilatation of the infra-renal aorta to a diameter of 30 mm. AAA is generally asymptom... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Completed) GB (Completed) DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-002448-25 | Sponsor Protocol Number: MA3RSTrial | Start Date*: 2012-10-02 | |||||||||||
Sponsor Name:University of Edinburgh [...] | |||||||||||||
Full Title: Magnetic Resonance Imaging Using Ultrasmall Superparamagnetic Particles of Iron Oxide in Patients Under Surveillance for Abdominal Aortic Aneurysms to Predict Rupture or Surgical Repair: the MA3RS ... | |||||||||||||
Medical condition: Abdominal Aortic Aneurysm | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-004604-29 | Sponsor Protocol Number: 210710120713 | Start Date*: 2015-04-27 | |||||||||||
Sponsor Name:Jens Rolighed Larsen | |||||||||||||
Full Title: Sevoflurane versus standard general anesthesia in elective open abdominal aortic aneurism surgery | |||||||||||||
Medical condition: Abdominal aortic aneurism | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2004-004983-56 | Sponsor Protocol Number: 3010410 | Start Date*: 2005-02-28 |
Sponsor Name:Hull and East Yorkshire Hospitals NHS Trust [...] | ||
Full Title: A randomised placebo controlled trial of pre-operative statin use in elective abdominal aortic aneurysm repair to determine the effect on systemic and cellular responses of ischaemia reperfusion in... | ||
Medical condition: Ischaemia reperfusion injury following elective abdominal aortic aneurysm repair. This occurs when muscle or organ is subjected to an ischaemic insult with associated damage followed by reperfusio... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2015-003674-32 | Sponsor Protocol Number: 1.1:12-6-2015 | Start Date*: 2016-02-23 |
Sponsor Name:Leiden University Medical Center | ||
Full Title: The effect of Telmisartan on inflammatory processes in the vascular wall of abdominal aortic aneurysms. | ||
Medical condition: Abdominal aortic aneurysm with an indication for elective open surgical repair. | ||
Disease: | ||
Population Age: Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2005-000195-41 | Sponsor Protocol Number: 091269 | Start Date*: 2005-06-14 |
Sponsor Name:The Leeds Teaching Hospitals NHS Trust | ||
Full Title: To investigate the effect of methylprednisolone on inflammatory cytokines and urinary N-acetyl-beta-D-glucosaminidase/creatinine ratio in elective aortic aneurysm repair. | ||
Medical condition: Abdominal aortic aneurysm, unruptured. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2015-003073-15 | Sponsor Protocol Number: 0504 | Start Date*: 2016-02-12 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sponsor Name:Research Governance, University of Leicester | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Full Title: HYDration and bicarbonate to prevent acute Renal injury after endovascular Aneurysm repair: pilot-feasibility randomized controlled study (HYDRA pilot trial) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Medical condition: Acute kidney injury post endovascular repair of the abdominal aortic aneurysm. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Trial protocol: GB (Completed) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2008-001732-13 | Sponsor Protocol Number: SPIO_180308 | Start Date*: 2008-09-03 |
Sponsor Name:University of Edinburgh | ||
Full Title: Magnetic Resonance Imaging of Aortic Aneurysm Instability | ||
Medical condition: Abdominal Aortic Aneurysm disease | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2006-006887-44 | Sponsor Protocol Number: RGHT000396 | Start Date*: 2007-06-19 | |||||||||||
Sponsor Name:Royal Group Hospitals Trust | |||||||||||||
Full Title: Non-invasive bed-side measurement of systemic endothelial function in patients undergoing abdominal aortic aneurysm repair; modulation by ascorbic acid | |||||||||||||
Medical condition: Abdominal Aortic Aneurysm | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-000899-25 | Sponsor Protocol Number: FP1CLI006 | Start Date*: 2016-12-16 | |||||||||||
Sponsor Name:Faron Pharmaceuticals Ltd | |||||||||||||
Full Title: A Phase II Double-blind, Randomised, Parallel Group 2:1 Comparison of the Efficacy and Safety of FP-1201-lyo (Recombinant Human Interferon Beta-1a) and Placebo in the Prevention of Multi-Organ Fail... | |||||||||||||
Medical condition: Prevention of Multi-Organ Failure on Patients Surviving Open Surgery for a Ruptured Abdominal Aortic Aneurysm. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FI (Prematurely Ended) EE (Prematurely Ended) LT (Prematurely Ended) GB (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-016709-41 | Sponsor Protocol Number: FIB692 | Start Date*: 2010-01-26 |
Sponsor Name:NHS Lothian [...] | ||
Full Title: Coagulopathy during surgery for the repair of Extent 4 Thoraco-Abdominal Aortic Aneurysms - feasibility study of the use of Fibrinogen Concentrate by infusion in place of Fresh Frozen Plasma. | ||
Medical condition: Coagulation disturbance during thoracoabdominal aneurysm repair. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2013-001447-31 | Sponsor Protocol Number: 954 | Start Date*: 2014-01-14 |
Sponsor Name:Liverpool Heart and Chest Hospital NHS Foundation Trust | ||
Full Title: A randomised controlled trial to study the effect of acetazolamide on the incidence of blood-stained CSF, effect on cerebrospinal fluid (CSF) pressure, CSF drainage and neurological dysfunction in ... | ||
Medical condition: Elevated cerebrospinal fluid pressure in patients undergoing thoracic-abdominal aortic repair | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2005-002942-20 | Sponsor Protocol Number: EFC5826 | Start Date*: 2005-12-29 | |||||||||||
Sponsor Name:sanofi-aventis recherche et developpement | |||||||||||||
Full Title: Randomized, multinational, multicenter, double-blind, placebo-controlled, two-arm parallel group trial of rimonabant 20 mg OD for reducing the risk of major cardiovascular events in abdominally obe... | |||||||||||||
Medical condition: Patients with abdominal obesity at increased risk for cardiovascular events (myocardial infarctio, stroke and cardiovascular death) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Prohibited by CA) GB (Prematurely Ended) ES (Completed) DE (Completed) AT (Prematurely Ended) FI (Completed) BE (Completed) DK (Suspended by CA) HU (Completed) CZ (Suspended by CA) IE (Prematurely Ended) PT (Completed) GR (Completed) IT (Prematurely Ended) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
